The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity

Objective. To evaluate the influence of combined therapy of sitagliptin and metformin on fat metabolism in patients with type 2 diabetes mellitus.Methods. The study included 82 patients (age, 55.3±9.1 years) with obesity and lipid metabolism disorders. None of the patients had reached their target g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aleksander Sergeevich Ametov, Dinara Gadgimagomedovna Gusenbekova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2015
Materias:
Acceso en línea:https://doaj.org/article/b13f9ca0f1714b428c8f9802849ce023
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!